Downregulation of MHC-I expression is prevalent but reversible in Merkel cell carcinoma.

Saved in:
Bibliographic Details
Title: Downregulation of MHC-I expression is prevalent but reversible in Merkel cell carcinoma.
Authors: Paulson KG; Department of Medicine, Division of Dermatology, University of Washington, Seattle, Washington., Tegeder A; Department of Medicine, Division of Dermatology, University of Washington, Seattle, Washington., Willmes C; Department of Dermatology, University Hospital Würzburg, Würzburg, Germany., Iyer JG; Department of Medicine, Division of Dermatology, University of Washington, Seattle, Washington., Afanasiev OK; Department of Medicine, Division of Dermatology, University of Washington, Seattle, Washington., Schrama D; Department of Dermatology, University Hospital Würzburg, Würzburg, Germany. Department of Dermatology, Medical University of Graz, Graz, Austria., Koba S; Department of Medicine, Division of Dermatology, University of Washington, Seattle, Washington., Thibodeau R; Department of Medicine, Division of Dermatology, University of Washington, Seattle, Washington., Nagase K; Department of Medicine, Division of Dermatology, University of Washington, Seattle, Washington., Simonson WT; Department of Pathology, University of Washington, Seattle, Washington. Department of Laboratory Medicine, University of Washington, Seattle, Washington., Seo A; Department of Medicine, Division of Dermatology, University of Washington, Seattle, Washington., Koelle DM; Department of Laboratory Medicine, University of Washington, Seattle, Washington. Department of Medicine, Division of Infectious Disease, University of Washington, Seattle, Washington. Department of Global Health, University of Washington, Seattle, Washington. Fred Hutchinson Cancer Research Center, Seattle, Washington., Madeleine M; Fred Hutchinson Cancer Research Center, Seattle, Washington., Bhatia S; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, Washington., Nakajima H; Department of Dermatology, Kochi Medical School, Kochi University, Kochi, Japan., Sano S; Department of Dermatology, Kochi Medical School, Kochi University, Kochi, Japan., Hardwick JS; Merck and Co. Inc., West Point, Pennsylvania., Disis ML; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, Washington., Cleary MA; Merck and Co. Inc., West Point, Pennsylvania., Becker JC; Department of Dermatology, Medical University of Graz, Graz, Austria. Department for Translational Dermato-Oncology (DKTK), University Hospital Essen, Essen, Germany., Nghiem P; Department of Medicine, Division of Dermatology, University of Washington, Seattle, Washington. Department of Pathology, University of Washington, Seattle, Washington. Fred Hutchinson Cancer Research Center, Seattle, Washington. pnghiem@uw.edu.
Source: Cancer immunology research [Cancer Immunol Res] 2014 Nov; Vol. 2 (11), pp. 1071-9. Date of Electronic Publication: 2014 Aug 12.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2326-6074
DOI:10.1158/2326-6066.CIR-14-0005